ACCESS study: blood pressure effect?
Michel
P
P
Bogousslavsky
J
J
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use*; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D001794:Blood Pressure; D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D015986:Confounding Factors, Epidemiologic; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D020521:Stroke / Q000150:complications / Q000188:drug therapy*; D013777:Tetrazoles; D013997:Time Factors
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C077793:candesartan cilexetil